Healthcare >> CEO Interviews >> January 13, 2000
LEONARD BELL, M.D. is the principal founder of Alexion, and, since 1992,
the President, Chief Executive Officer, and a Director of the Company.
Alexion became a publicly traded company on the NASDAQ National Market
in 1996. From 1990 to 1993, Dr. Bell was an Assistant Professor in the
Department of Internal Medicine (Cardiology) at the Yale University
School of Medicine as well as an Attending Physician at the Yale-New
Haven Hospital and, from 1991-1993, an Assistant Professor in the
Department of Pathology and co-Director of the Program in Vascular
Biology at Yale Medical School. Dr. Bell was the recipient of the
Physician Scientist Award from the National Institutes of Health. From
1986 through 1990, Dr. Bell did various postdoctoral research and
clinical training in Cardiology and Pathology at the Yale Medical
School. Dr. Bell is the recipient of various honors and awards from
academic and professional organizations and his work has resulted in
more than 45 scientific publications, invited presentations and patent
applications. Dr. Bell is a Director of CURE and an invited Member of
the State of Connecticut Governor's Council on Economic Competitiveness
and Technology. Dr. Bell received his A.B. from Brown University and
M.D. from Yale University. Dr. Bell received his clinical training from
Yale University in internal medicine and cardiology and is currently an
Adjunct Assistant Professor of Medicine and Pathology at Yale. Profile
Dr. Bell: I was the principal founder of Alexion in 1992. We have
focused on developing novel anti-inflammatory drugs. We
